Howard S Rosenzweig

Title: Howard S. Rosenzweig: Innovator in Chemical Modification of Antibodies

Introduction

Howard S. Rosenzweig is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of monoclonal antibodies. His innovative work has led to the development of a unique method for the regioselective chemical modification of these important biological molecules.

Latest Patents

Howard S. Rosenzweig holds a patent for a method titled "Regioselective chemical modification of monoclonal antibodies." This patent describes a technique for selectively modifying an immunoglobulin that has at least one Fab region and one Fc region. The method involves modifying the immunoglobulin at a pH that lies between the respective isoelectric points of the Fab and Fc fragments, allowing for precise alterations in the antibody's structure.

Career Highlights

Rosenzweig is affiliated with the University of Pittsburgh, where he continues to engage in research and development. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in various therapeutic contexts. With a total of 1 patent, he has established himself as a key figure in his field.

Collaborations

Some of his notable coworkers include Girish Ranadive and Michael Wayne Epperly. Their collaborative efforts have contributed to the success of various research projects and innovations within the university.

Conclusion

Howard S. Rosenzweig's contributions to the field of chemical modification of antibodies highlight his role as an innovator in biochemistry. His work continues to influence the development of new therapeutic strategies.